Comparing Local and Systemic Control between Partial- and Whole-Breast Radiotherapy in Low-Risk Breast Cancer—A Meta-Analysis of Randomized Trials

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Cancers 13.12 (2021): 2967.

Event: Veröffentlichung

(where): Erlangen

(who): Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

(when): 2021

Creator: Haussmann, Jan
Budach, Wilfried
Strnad, Vratislav
Corradini, Stefanie
Krug, David
Schmidt, Livia
Tamaskovics, Balint
Bölke, Edwin
Simiantonakis, Ioannis
Kammers, Kai
Matuschek, Christiane

DOI: 10.3390/cancers13122967

URN: urn:nbn:de:bvb:29-opus4-167520

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Haussmann, Jan
Budach, Wilfried
Strnad, Vratislav
Corradini, Stefanie
Krug, David
Schmidt, Livia
Tamaskovics, Balint
Bölke, Edwin
Simiantonakis, Ioannis
Kammers, Kai
Matuschek, Christiane
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

Time of origin

2021

Other Objects (12)

$Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice$

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice

$Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)$

Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Stereotaktische Radiotherapie plus Nivolumab bei NSCLC

Simultan-integrierter Boost bei moderat hypofraktionierter adjuvanter Radiotherapie der Brust

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation : = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy

Current controversies in radiotherapy for breast cancer

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences

$Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice$

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice

Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Stereotaktische Radiotherapie plus Nivolumab bei NSCLC

Simultan-integrierter Boost bei moderat hypofraktionierter adjuvanter Radiotherapie der Brust

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation : = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy

Current controversies in radiotherapy for breast cancer

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences

$Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice$

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice

Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Stereotaktische Radiotherapie plus Nivolumab bei NSCLC

Simultan-integrierter Boost bei moderat hypofraktionierter adjuvanter Radiotherapie der Brust

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation : = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy

Current controversies in radiotherapy for breast cancer

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Comparing Local and Systemic Control between Partial- and Whole-Breast Radiotherapy in Low-Risk Breast Cancer—A Meta-Analysis of Randomized Trials

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice

Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Stereotaktische Radiotherapie plus Nivolumab bei NSCLC

Simultan-integrierter Boost bei moderat hypofraktionierter adjuvanter Radiotherapie der Brust

Current controversies in radiotherapy for breast cancer

Current controversies in radiotherapy for breast cancer

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice

Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Stereotaktische Radiotherapie plus Nivolumab bei NSCLC

Simultan-integrierter Boost bei moderat hypofraktionierter adjuvanter Radiotherapie der Brust

Current controversies in radiotherapy for breast cancer

Current controversies in radiotherapy for breast cancer

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice

Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Stereotaktische Radiotherapie plus Nivolumab bei NSCLC

Simultan-integrierter Boost bei moderat hypofraktionierter adjuvanter Radiotherapie der Brust

Current controversies in radiotherapy for breast cancer

Current controversies in radiotherapy for breast cancer

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences

Related objects

Reset password